Chaccour and colleagues published an interesting study in the NEJM investigating whether giving ivermectin monthly for 3 months during the rainy season would reduce the incidence of malaria compared to albendazole. Emerging resistance to insecticides and behavioural changes in mosquito biting activity mean that other methods of vector control are important. Mass administration of an antiparasitic to humans which would then kill mosquitoes feeding on those humans could be a useful public health intervention in endemic malarial areas.

Read the article here.